• Music Therapy Helps Relieve Pain in Adults with Sickle Cell Disease, Pilot Trial Suggests
  • Kids with Sickle Cell Disease and Sleep Apnea at Higher Risk of Complications, Study Finds
  • First Results from Phase 3 Trial Expected to Support FDA’s Accelerated Approval of Voxelotor for Sickle Cell
  • Gene Therapy LentiGlobin Continues to Show Good Results, Bluebird Bio Says
  • Sickle Cell Disease Association and Emmaus Partner to Increase Education, Awareness
  • Sickle Cell Disease Association Launches First Patient-powered Registry
  • MaxCyte and NIH Office Partner to Develop Cell Therapy for Sickle Cell Disease
  • Potential Treatment Targeting Nitric Oxide Levels, Olinciguat, Named Orphan Drug by FDA
  • Platform to Diagnose, Monitor SCD Wins Vodafone Wireless Innovation Project Grant
  • Potential Sickle Cell Treatment Altemia Shows Promise in Phase 2 Trial, Data Reports
  • FDA Places Clinical Hold on IND Application for CTX001 for Sickle Cell Disease
  • US ‘Right to Try’ Law Meets with Mix of Praise and Criticism, Including Among Those with Rare Diseases